hydration effects glp-1 receptor agonist therapy 2025 Exploring the Side of Agonist: To Ensure Its Optimal Positioning Muscle loss and GLP-1R agonists
Description
Anagliptin, a potent dipeptidyl peptidase IV inhibitor: its single-crystal structure and enzyme interactions
Abbreviations ADA, American diabetes association
Glucagon-like peptide 1 induces pancreatic -cell proliferation via transactivation of the epidermal growth factor receptor
Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities
Application Analysis The type 2 diabetes mellitus segment had a tremendous growth rate, with a revenue share of 62.3% owing to the well-established role of GLP-1 receptor agonists in improving glycemic control, promoting weight loss, and offering cardiovascular benefits in patients with type 2 diabetes
Front Pharmacol 2022;13:925377.ArticlePubMedPMC 55
